APOE and Alzheimer disease: It was notable that in non–community-based samples across Black and White groups, there was similar AD risk associated with APOE*23 (slightly more protective in White individuals), and in Black individuals, APOE*34 and APOE*44 outcome estimates showed greater AD risk compared with what was observed in primary analyses.